Multifocal Motor Neuropathy Trial to Proceed Following FDA Clearance
According to a story from BioSpace, the biotech company Dianthus Therapeutics recently announced that the US Food and Drug Administration (FDA) has cleared the company's phase 2 clinical trial. This…